For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Nasogastric Tube refers to a tube that is passed through the nose and down through the nasopharynx and esophagus into the stomach. It is a flexible tube made of rubber or plastic, and it has bidirectional potential. It can be used to remove the contents of the stomach, including air, to decompress the stomach, or to remove small solid objects and fluid, such as poison, from the stomach. An NG tube can also be used to put substances into the stomach, and so it may be used to place nutrients directly into the stomach when a patient cannot take food or drink by mouth.
Nasogastric tubes (NGT) still remain the simple and best way for the gastrointestinal tract access. The NGT placing is one of the most commonly performed procedures in emergency medical cases. NG tube passes through the nose and down the nasopharynx and esophagus into the stomach. The tube can be used to remove the contents of the stomach and deliver the important nutritional and medicinal support to ill patients. Premature and sick babies have a limited supply of energy and nutrients. The NG tubes deliver the nutrients and medicinal support in these emergency cases. Moreover, many critical conditions associated with swallowing disorders such as dementia, amyotrophic lateral sclerosis, neurological diseases, physical obstruction, and stroke require NG tubes to provide nutritional and medicinal support for ill patients.
The Nasogastric Tube market revenue was 267.76 Million USD in 2022, and will reach 332.77 Million USD in 2028, with a CAGR of 3.69% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Nasogastric Tube industry, and breaks down according to the type, application, and consumption area of Nasogastric Tube. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Nasogastric Tube in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Nasogastric Tube market covered in Chapter 11:
Q Holding Company
Avanos
Bicakcilar
GBUK Group Ltd.
BD
Rontis
Cardinal Health
Andersen Products
Guangdong Baihe Medical Technology
Pacific Hospital Supply
In Chapter 3, on the basis of types, the Nasogastric Tube market from 2018 to 2028 is primarily split into:
Levin Tube
Sengstaken-Blakemore Tube
In Chapter 4, on the basis of applications, the Nasogastric Tube market from 2018 to 2028 covers:
Children Use
Adult Use
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028